
Eris Lifesciences Investor Relations Material
Latest events

Q1 25/26
Eris Lifesciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Eris Lifesciences Limited
Access all reports
Eris Lifesciences Limited is an India-based pharmaceutical company engaged in the development, manufacturing, and marketing of branded formulations. The company focuses on therapeutic areas such as cardiovascular, diabetes, neurology, gastroenterology, and dermatology. It primarily caters to the domestic market, targeting healthcare professionals and patients through its portfolio of prescription medicines. The company is headquartered in Ahmedabad, India, and its shares are listed on the NSE and BSE.
Key slides for Eris Lifesciences Limited


Q3 24/25
Eris Lifesciences Limited


Q4 24/25
Eris Lifesciences Limited
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
ERIS
Country
🇮🇳 India